<< Back To Home

NEW THIS SATURDAY: IMPACT OF PYRETHROID RESISTANCE ON OPERATIONAL MALARIA CONTROL IN MALAWI

Friday, 12th of July 2013 Print



  • IMPACT OF PYRETHROID RESISTANCE ON OPERATIONAL MALARIA CONTROL IN MALAWI

Charles S. Wondjia,1,  Michael Colemana,1, Immo Kleinschmidtb, Themba Mzilahowac, Helen Irvinga, Miranda Ndulaa, Andrea Rehmanb, John Morgana, Kayla G. Barnesa, and Janet Hemingwaya,2

Author Affiliations

aLiverpool School of Tropical Medicine, Liverpool L3 5QA, United Kingdom;

bLondon School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom; and

cMalaria Alert Centre, College of Medicine, Blantyre, Malawi

Contributed by Janet Hemingway, October 4, 2012 (sent for review July 29, 2012)

 

Abstract below; full text, with figures, is best viewed at http://www.pnas.org/content/109/47/19063.full?sid=80c572c9-cdb0-4fa2-a4a5-f5e26379784f

The impact of insecticide resistance on insect-borne disease programs is difficult to quantify. The possibility of eliminating malaria in high-transmission settings is heavily dependent on effective vector control reducing disease transmission rates. Pyrethroids are the dominant insecticides used for malaria control, with few options for their replacement. Their failure will adversely affect our ability to control malaria. Pyrethroid resistance has been selected in Malawi over the last 3 y in the two major malaria vectors Anopheles gambiae and Anopheles funestus, with a higher frequency of resistance in the latter. The resistance in An. funestus is metabolically based and involves the up-regulation of two duplicated P450s. The same genes confer resistance in Mozambican An. funestus, although the levels of up-regulation differ. The selection of resistance over 3 y has not increased malaria transmission, as judged by annual point prevalence surveys in 1- to 4-y-old children. This is true in areas with long-lasting insecticide-treated nets (LLINs) alone or LLINs plus pyrethroid-based insecticide residual spraying (IRS). However, in districts where IRS was scaled up, it did not produce the expected decrease in malaria prevalence. As resistance increases in frequency from this low initial level, there is the potential for vector population numbers to increase with a concomitant negative impact on control efficacy. This should be monitored carefully as part of the operational activities in country.

The push for malaria elimination and eventual eradication will be heavily dependent on our ability to reduce disease transmission. A recent editorial suggests that we have the tools to take on this challenge in African malaria heartlands (1). This is predicated on ensuring that vector control prevention and drug treatment tools are fully deployed, reaching every person at risk. There will need to be improved delivery of these tools and better clinical management of malaria cases. In highly endemic areas our ability to reduce malaria transmission will be dependent on vector control, before the focus can shift to killing the parasite in infected people. Two forms of vector control, indoor residual spraying (IRS) and the distribution of long-lasting insecticide-treated nets (LLINs) have been demonstrated to reduce transmission when properly deployed against insecticide susceptible mosquito populations. The use of both interventions has dramatically increased since 2000 in many malaria endemic countries, with increased donor funding to attain the Roll Back Malaria targets and support the malaria elimination agenda (2).

IRS and LLINs function by reducing the female mosquito daily survival rate and human biting frequency. Pyrethroids are the only insecticides recommended for use on LLINs, and only four chemical classes of insecticides that attack two target sites are available for IRS, and again pyrethroids dominate the IRS market. Resistance to pyrethroids has been selected in Anopheles gambiae and Anopheles funestus, the major African malaria vectors, although the frequency and level (fold) resistance conferred can vary dramatically. The impact of this resistance on the ability of either control intervention to reduce disease transmission is poorly understood, and current monitoring and evaluation practices are not sufficiently robust to assess this unless catastrophic failures occur. The perceived threat of pyrethroid resistance is now sufficiently high for the World Health Organization (WHO) to convene an international multidonor effort to counteract this.

Operationally significant pyrethroid resistance has the potential to limit effective malaria control, owing to the small number of alternative public health insecticides. Pyrethroid resistance in malaria vectors has increased dramatically over the last decade (3, 4), particularly in Africa, where the bulk of malaria-related mortality occurs. Typically resistance is monitored by bioassays, for which the WHO has defined a diagnostic dosage for each insecticide that kills susceptible anopheline mosquitoes (5). Mosquitoes surviving the diagnostic dosage are an indication that resistance has been selected and that an operational problem may be developing, but bioassays alone do not signify control failure.

Little operational monitoring of the underlying mechanisms of resistance occurs. Two mechanisms are predominantly responsible for insecticide resistance: changes in the insecticide target site, reducing binding of the insecticide, and increases in the rate at which the insecticide is metabolized (6). Information on the resistance mechanisms is more predictive than bioassays, providing information on the level of resistance and potential cross-resistance between insecticides. For example, two common mutations in the sodium channel convey low-level resistance to pyrethroids and higher-level resistance to dichlorodiphenyltrichloroethane (DDT) in An. gambiae (7, 8), whereas a cytochrome P450-based metabolic regulatory mechanism conveys very high-level pyrethroid and low-level carbamate resistance in An. funestus (9).

Vector control interventions are being rapidly scaled up in Malawi, where malaria is highly endemic. Malaria accounts for 34% of all outpatient hospital visits and is the main cause of hospital admissions in children aged <5 y (10). Before 2007 sporadic WHO bioassays were undertaken, which indicated that the two major malaria vectors, An. gambiae and An. funestus, remained fully susceptible to pyrethroids. In 2007 pyrethroid-impregnated LLINs were distributed through antenatal and under-5 clinics at district and central hospitals countrywide. The numbers distributed were sufficient to achieve the Roll Back Malaria targets of 80% of pregnant women and children aged <5 y sleeping under a treated net. In 2008, a pilot study of IRS with the pyrethroid lambda cyhalothrin (ICON, Syngenta) was initiated in Nkhota Khota District, supported by the Presidents Malaria Initiative (PMI). The initial program targeted 26,950 houses, and was expanded to 74,772 houses in 2009. Approximately 4 million LLINs were procured and ∼2 million distributed during this time. In 2010 the PMI-supported IRS was expanded to cover the whole of Nkohta Khota district, and the Malawian Ministry of Health supported IRS in a further six districts.

A series of sentinel sites were established during this period to track the effect of this rapid increase in insecticide selection pressure on the local vectors and assess any impact on malaria transmission. This was particularly pertinent owing to the high levels of pyrethroid resistance reported in the southern part of neighboring Mozambique in An. funestus, which had prompted a switch from pyrethroids to carbamates or DDT for IRS in the Lubombo Spatial Development Initiative area of Mozambique (11, 12).

Previous SectionNext Section

Results and Discussion

Few operational reports exist to compare the impact of insecticide resistance directly on epidemiological outcomes of disease, owing to the number of confounding factors. Most studies have been undertaken with LLINs, often in experimental hut settings, and use entomological outcomes to assess the effect of insecticide resistance on mosquito biting rates, blood feeding rates, or insect mortality (1315). Even these data are difficult to interpret, because of variation in experimental design and inconsistent and often poor-quality insecticide resistance monitoring of the vector population.

Recently Malawi has begun to scale up its malaria control program with LLIN and IRS initiatives. By monitoring these activities in 12 sentinel sites as they are scaled up, and simultaneously assessing pyrethroid resistance levels in the malaria vectors over the period that resistance was initially selected, this study provides an initial assessment of the impact of known pyrethroid resistance mechanisms on an operational malaria control program.

Insecticide Resistance Detection.

An early indicator of the selection of resistance in South Africa was the presence of An. funestus resting inside sprayed houses (16). Over the course of 2009–2010 in Malawi it became easier to find An. funestus in substantial numbers resting inside recently insecticide-sprayed houses. A total of 460 resting female Anopheles mosquitoes were collected inside houses from 12 localities between April 2009 and April 2010. Of these, 340 were morphologically identified as belonging to the An. funestus group and 120 to the An. gambiae complex.

WHO bioassays were carried out on 2,579 F1 Anopheles offspring from 12 sentinel sites (Fig. 1) and on a further 1,115 An. funestus from the Chikwawa site using randomly mixed F1 individuals. An. funestus from the sentinel sites were resistant to the carbamate, bendiocarb (24–45% survival), and three pyrethroids (8–66% survival) (Table 1). There was no evidence of organophosphate or DDT resistance. The An. funestus population from Chikwawa had 53% survival of females and 42% survival of males after exposure to the discriminating dosage for permethrin. Marginally higher levels of resistance (58% female and 48% male survival) were recorded for deltamethrin. The Chikwawa population was also resistant to bendiocarb and had low levels of resistance to DDT, but was fully susceptible to dieldrin.

View larger version:

In this page

In a new window

Download as PowerPoint Slide

Fig. 1.

Map of Malawi showing the localization of the different collection sites.

View this table:

In this window

In a new window

Table 1.

WHO susceptibility test results on 2- to 5-d-old F1 An. gambiae and An. funestus

An. gambiae had lower levels of resistance than An. funestus, but permethrin resistance was detected at all sentinel sites tested, and at one none-IRS site (Nkhwazi) there was also resistance to lambda cyhalothrin. The same field populations of both species tested in 2007 was fully susceptible (100% mortality) to all insecticides (Table 1).

In contrast to DDT resistance selection in several African locations during the first malaria eradication campaign, where An. gambiae rapidly became resistant whereas An. funestus populations were often eliminated, in Malawi An. funestus has been selected for pyrethroid resistance more rapidly than An. gambiae. Hence, where both vectors are present it should not be assumed that An. funestus will be easily controlled by the introduction of pyrethroids.

Biochemical Assays.

Efforts to elucidate the underlying mechanisms of resistance focused on An. funestus, for which increased numbers resting on sprayed surfaces, higher resistance levels, and greater numbers suggested there might be the greatest impact on disease transmission. Many of the enzyme systems involved in insecticide resistance are controlled by common regulatory cascades, hence a change in a single regulator can affect the production of multiple enzymes from different classes, making it impossible from simple biochemical assays to extrapolate to the number of resistance genes that have been selected. These assays do, however, indicate a shift in metabolic activity that can then be further characterized.

The biochemical assays indicated that the Malawian An. funestus population had increased metabolic activity of several enzyme families compared with a standard susceptible An. gambiae laboratory population, which has metabolic activity levels consistent with a raft of different insecticide susceptible Anopheles mosquito species. Elevated esterases can produce organophosphate, carbamate, or pyrethroid resistance. Resistance to the first two insecticide classes has been routinely associated with activity that can be detected with the substrates α- and β-naphthyl acetate. There was a significant (1.82-fold) increase in esterase activity with the substrate p-nitrophenyl acetate (pNPA) in the Chikwawa population compared with the Kisumu susceptible strain (P = 0.027) (Fig. 2A). In contrast no increase was seen with either of the naphthyl acetate substrates.

View larger version:

In this page

In a new window

Download as PowerPoint Slide

Fig. 2.

Box plots of results from biochemical assays. The median activity of the An. funestus population of Chikwawa compared with the An. gambiae Kisumu reference strain is shown by a horizontal bar; the box denotes the upper and lower quartiles. The vertical lines show the full range of the data set. (A) Range of esterase activity with the substrate p-nitrophenyl acetate; (B) acetylcholinesterase inhibition ranges. (C) Range of GST activity. (D) Estimated levels of cytochrome P450s (representing monooxygenase activity).

A significant increase in the level of GST activity was observed in Chikwawa, with mean chlorodinitrobenzene levels 2.05-fold higher than Kisumu (P < 0.0084) (Fig. 2C). GSTs break down DDT and catalyze secondary metabolic detoxification pathways for many other insecticides.

The greatest increase was seen with monooxygenases: a 2.35-fold increase in total monooxygenases was detected in the Chikwawa population (Table 2). The biochemical data are consistent with one or more metabolic resistance mechanisms having been selected in the Malawian An. funestus, which warranted further molecular characterization.

View this table:

In this window

In a new window

Table 2.

Comparisons of average values for a range of biochemical assays between F1 adult progeny An. funestus from Chikwawa populations and the An. gambiae Kisumu insecticide susceptible reference strain

Acetycholinesterase (AChE) inhibition rates with the carbamate propoxur were similar in the resistant and susceptible strains (Fig. 2B). The lack of an altered target site resistance mechanism for organophosphates or carbamates was further confirmed by sequencing and hence can be discounted, suggesting that the bendiocarb and pyrethroid resistances detected by bioassay have a metabolic basis.

Transcription Profiling of Candidate P450 Genes.

The increase in monooxygenase levels seen by biochemical assay prompted the assessment of expression levels of the two P450 genes (CYP6P9a and CYP6P9b) that are primarily responsible for pyrethroid resistance in An. funestus in a laboratory strain and from field-collected insects from neighboring Mozambique (17). Expression levels were assessed in individuals that were known to be permethrin or bendiocarb resistant, and these were compared with susceptible or control mosquitoes from the same population that had not been exposed to insecticide. Quantitative PCR showed that CYP6P9a was consistently and significantly more over-expressed than CYP6P9b (P < 0.01). The increased expression was apparent in permethrin resistant (1.65-fold), bendiocarb resistant (3.15-fold), and control (2.15-fold) individuals compared with susceptibles (Fig. 3A). This expression pattern differs from that observed in pyrethroid resistant Mozambican An. funestus, in which both P450s have a comparable level of expression, with CYP6P9b being slightly but nonsignificantly higher. The lower fold change difference between both genes in permethrin resistant insects may indicate that both enzymes are involved in pyrethroid metabolism, whereas only CYP6P9a may play a role in bendiocarb metabolism.

View larger version:

In this page

In a new window

Download as PowerPoint Slide

Fig. 3.

(A) Schematic representation of haplotypes (H) of the 917-bp portion of the VGSC observed in the Chikwawa population. Only polymorphic sites are shown, and these are numbered from the beginning of the 917-bp sequence. Dots mean identity with the first sequence. A number has been given to each haplotype preceded by the letter R or S if it is unique to the resistant or susceptible sample, respectively. In case of a shared haplotype, the number is preceded by an asterisk. The column (N) indicates the number of individuals sharing the haplotype. Below the list of haplotypes, R or S indicates the positions that are polymorphic in the resistant or susceptible mosquitoes, respectively, whereas an asterisk marks a position polymorphic in both phenotypes. (B) Neighbor-joining tree of the VGSC haplotypes from Chikwawa. (C) Distribution of the sodium channel gene haplotypes between susceptible and resistant mosquitoes from Chikwawa.

The expression profile of CYP6P9a shows that this gene had significantly higher expression in permethrin resistant mosquitoes than in bendiocarb resistant ones (1.69-fold change; P < 0.001) (Fig. 3B). It was also more highly expressed in permethrin resistant than in control mosquitoes (not exposed to insecticide), although the difference was not significant (1.27-fold change). CYP6P9a expression in control insects was higher than in bendiocarb resistant mosquitoes, although the difference was not significant (1.33-fold change).

CYP6P9b was significantly over expressed (3.24 fold, P < 0.001) in permethrin resistant compared with bendiocarb resistant ones, compared with 1.68 for CYP6P9a (Fig. 3C). The expression of CYP6P9b in permethrin resistant mosquitoes was significantly higher than in bendiocarb resistant ones (1.95-fold, P < 0.05). Both CYP6P9a and CYP6P9b were significantly overexpressed in all of the samples tested compared with the susceptible strain FANG (Fig. 3B, P < 0.001). The highest fold change for both enzymes was observed in permethrin resistant compared with FANG (8.9- and 10.5-fold change, respectively), followed by nonexposed/FANG comparison with 7.1- and 6.3-fold change, respectively, supporting the potential role of these two genes in pyrethroid resistance in Chikwawa.

Mutations of the Sodium Channel Gene.

Resistance due to changes in the target site of pyrethroids and DDT can be directly assessed by sequencing the relevant section of the target site. A 994-bp fragment of the voltage-gated sodium channel (VGSC) gene was sequenced. A total of 10 Chikwawa An. funestus specimens were sequenced (5 permethrin resistant and 5 susceptible mosquitoes). A 917-bp sequence from this fragment previously aligned in pyrethroid resistant Ugandan mosquitoes (18) was aligned for all individuals. Table 3 shows that there were 10 polymorphic sites, with four transitions and six transversions. Ten polymorphic sites were recorded in the resistant samples and only one in the susceptibles. No polymorphic sites were observed in exon 20 containing the 1014 codon usually associated with kdr-type pyrethroid resistance in other Anopheles. Only five haplotypes were observed in total (one for the susceptibles and three for resistants, with one in common); in contrast, 18 haplotypes were found in the same fragment from Ugandan An. funestus. The haplotype sequences have been submitted to GenBank (accession nos. JN815112–JN815116).

View this table:

In this window

In a new window

Table 3.

Summary statistics for polymorphism at the sodium channel gene in susceptible and resistant An. funestus from Chikwawa, Malawi

The correlation between patterns of polymorphism and resistant phenotype was further confirmed by the neighbor-joining tree showing specific clades for resistant and susceptible individuals (Fig. 4B). This correlation suggests that although a 1014 mutation was not identified in Malawian samples, changes in the VGSC gene may still confer permethrin resistance. To confirm that changes in 1014 were not present, pyrosequencing was undertaken on 50 field-collected An. funestus. Pyrogram traces showed only the 1014 TTA codon, indicating that they did not have the L1014F (TTA to TTT) or L1014S (TTA to TCA) kdr mutations. More detailed analysis is ongoing to ascertain whether any of the resistance phenotype can be mapped to the sodium channel locus.

View larger version:

In this page

In a new window

Download as PowerPoint Slide

Fig. 4.

Transcription profile of candidate genes in the Chikwawa population. (A) Comparison of the patterns of gene expression of CYP6P9a and CYP6P9b for each sample. (B) Expression ratio of CYP6P9a and CYP6P9b for sample. The normalized expression ratio of each gene against RSP7 gene is represented on the vertical axis. (C) Fold change of CYP6P9a and CYP6P9b between different comparisons. P, permethrin resistant; B, bendiocarb resistant; C, nonexposed mosquitoes; S, FANG susceptible strain.

AChE Gene Sequencing.

A 1,290-bp fragment of the AChE gene was sequenced in 10 mosquitoes, 5 bendiocarb resistant and 5 susceptible mosquitoes. The G119S mutation that confers carbamate and organophosphate resistance in An. gambiae and Culex quinquefasciatus (19) was not detected in these samples, nor was the F455W mutation found in Cx tritaeniorhynchus (20). Several indels (from 2 to 45 nucleotides) were observed in the introns, but these were not correlated with resistance or geographical location. A high level of synonymous polymorphism was seen. Sequencing results support the biochemical assays, indicating that there is no target site resistance associated with the observed bendiocarb resistance in An. funestus from Chikwawa.

Thus, pyrethroid and bendiocarb resistance in Malawian An. funestus is linked to an increase in cytochrome P450s, with the potential for a target site resistance with a mutation distinct from the 1014 residue usually associated with sodium channel target site resistance in An. gambiae (7, 8). Similar patterns of pyrethroid resistance occur in An. funestus from Mozambique and South Africa (9, 21). It is possible that this resistance front has now extended north from Mozambique, or it may have been selected de novo in Malawi. The resistance patterns in the Malawian and Mozambican populations are similar, with metabolically based resistance to bendiocarb but not organophosphates. Resistance is associated with the up-regulation of a pair of related CYP6 P450s in both Malawian and Mozambican An. funestus. However, there is a major difference in expression levels of the two genes in the two populations. There is a consistently higher level of expression of the CYP6P9a gene in Malawi compared with CYP6P9b, whereas expression levels of the two genes are comparable in Mozambique. This result suggests that the regulatory mechanism underlying the resistance in the two countries may not be identical, although further work is required to confirm this. Up-regulation of members of the CYP6 rather than CYPM family of P450s is consistent with the lack of DDT resistance. Up-regulation of CYPM2 in West African An. gambiae produces high levels of both DDT and pyrethroid resistance (22), and any suggestion that this had been selected in either of the Malawian vectors may have reduced insecticide choice still further.

A comparison of the expression levels of both CYP6P9a and CYP6P9b in the bendiocarb resistant mosquitoes shows that both genes have significantly lower expression levels in the bendiocarb resistant compared with the permethrin resistant samples. This suggests that these P450s may preferentially metabolize pyrethroids. The involvement of these P450s in cross-resistance between the carbamate and pyrethroid resistances was previously indicated by piperonyl butoxide synergist assays (9).

Vector Control Coverage and Household Surveys.

IRS coverage in the five treatment districts was 88.5% in 2010. LLIN use by children aged <5 y was similar in IRS and non-IRS sites (50% and 54%, respectively). Introduction of this level of IRS coverage into a background of moderate to high LLIN use should rapidly produce an obvious reduction in parasite prevalence, as seen operationally in similar high malaria endemic areas such as Bioko, West Africa (23).

A total of 802 1- to 4-y-old children were surveyed in April 2009 for Plasmodium falciparum infection, with a follow up survey in 2010 involving 678 children. The refusal rate was negligible. Combined prevalence of infection across all sites in 2009 was 53.6% [confidence interval (CI) 43.6–63.4%], which was reduced in 2010 to 39.5% (27.6–52.9%). In the LLIN-only sites the reduction in prevalence from 2009 to 2010 was 53.2% (CI 40.4–65.5%) to 40% (23.4–59.1%), whereas the reduction in the IRS plus LLIN sites was from 54.9% (42.3–66.8%) to 38.6% (30.2–47.8%) (Table 4). In 2009 four districts—Kalungama, Kamekete, Makoka, and Mazanduwa—were sprayed by the National Malaria Control Program, with coverage ranging from 60.5% to 86.1%, protecting 126,126 people. IRS was expanded in 2010, and a fifth district (Ambali) was added. IRS coverage in 2010 ranged from 64.5% to 100%. The LLIN use combined for all sites increased from 43.9% to 52.7% [odds ratio (OR) 1.42, CI 0.97–2.09]. The larger increase in LLIN use was seen in the non-IRS districts, increasing from 41.4% to 54.1% (OR 1.69, CI 1.03–2.78) compared with the IRS districts, where LLIN use reduced slightly from 52.2% to 49.7% (OR 0.9, CI 0.63–1.3) (Table 4).

View this table:

In this window

In a new window

Table 4.

ITN use, IRS coverage, and prevalence in 1- to <5-y-olds at sentinel sites

However, for three IRS sites (Kalungama, Kamekete, and Makoka) the CIs indicated that the OR was not inconsistent with 1, suggesting no real change in prevalence despite the increased use of IRS.

Only five sentinel sites (Ambali, Chinkole, Davide, Mazanduw, and Nkhwazi) saw real evidence of a reduction in prevalence. Two of these were IRS districts, with IRS-only starting in Ambali in 2010; the other three sites had only LLINs. Four of the sites had evidence of either An. gambiae and/or An. funestus becoming resistant to pyrethroids. The resistance status was not assessed in the fifth site. Two of the “real impact” sites (Chinkole with LLINs and Mazanduwa with IRS) had high levels of resistance in An. funestus, but An. gambiae in Chinkole remained susceptible to deltamethrin.

In three LLIN-only sites (Chapola, Chiwalo, and Nkhoma) there was an increase in prevalence of infection in children aged <5 y (i.e., point estimates of ORs >1 for 2010 relative to 2009). However, none of these estimates are inconsistent with an OR = 1, as evident from the 95% CIs. It would therefore be more accurate to say that there was no evidence of a change in prevalence in these districts.

Within the current dataset the five sites with real reductions in prevalence had as many insecticide resistance reports as the nine sites with no reduction in prevalence, and two of the former had high levels of pyrethroid resistance in An. funestus. Hence although pyrethroid resistance in An. funestus has gone from undetectable levels in 2007 to moderate or high frequencies throughout the country, we have yet to demonstrate a major epidemiological impact on disease transmission. Pyrethroid susceptibility data, which can be linked to vector control impact indicators, are however needed in larger numbers of sites to be able to address this question with more statistical power.

Sufficient nets were distributed in the initial antenatal clinic campaign in Malawi to theoretically hit the 80% coverage target for pregnant women and children. In practice, net use across all of the sentinel sites within the study area was significantly lower, with 40–50% use. Despite this, pyrethroid resistance has appeared and spread rapidly in Malawian malaria vectors. Over the last 3 y the tipping point for resistance selection has been achieved, and the population has shifted dramatically from undetectable levels of resistance by bioassay to >50% of the population carrying one or more resistance genes. This shift in resistance has occurred at scale throughout the country and is not restricted to small areas where selection has been increased, for example by the introduction of pyrethroid-based IRS. Similar shifts have been noted in Aedes aegypti in Mexico (24), which is currently underpinning a major outbreak of dengue hemorrhagic fever (25). The speed at which this resistance has appeared and spread emphasizes the importance of high-quality routine screening if resistance is to be detected at an early stage.

The impact of this pyrethroid resistance on our ability to reduce transmission in Malawi still needs to be fully elucidated. Resistance was selected over a period of <3 y and has spread throughout Malawi in An. funestus, with a lower but evident increase in resistance in An. gambiae. The continued selection pressure with pyrethoids from the LLINs and further scale up of IRS with pyrethroids in 2010 will maintain and increase the pyrethroid resistance gene frequencies in the field population. If this is combined with favorable rainfall, it is likely to result in a net increase of mosquito population numbers, a large percentage of which will be less susceptible to the vector control in place. The current resistance has not triggered a major increase in parasite prevalence in Malawian children, but it may have reduced the benefit of introducing IRS in several districts. Those districts where IRS was used in Malawi showed similar prevalence levels and trends to the LLIN alone areas, in contrast to Equitorial Guineam, Bioko Island, and Zambezia Porvince, Mozambique, where IRS provided an added benefit in an LLIN background in the initial phases of its introduction (23).

The statistical power required to accurately detect such trends requires large-scale sampling. There are almost no operational control programs that operate annual point prevalence or alternative disease surveillance systems at this kind of scale, alongside appropriate entomological monitoring that could be used to assess trends linked to resistance selection. If these cannot be undertaken operationally, then pragmatically avoiding resistance selection by the judicious use of insecticides where practical in rotations, mosaics, or mixtures will be necessary. The choice of insecticides within these strategies should be guided by the resistance situation on the ground, which should include a clear understanding of the underlying resistance mechanisms, because the cross-resistance patterns may drive the strategy that is required.

Previous SectionNext Section

Materials and Methods

Area of Study and Mosquito Collection.

Fourteen sentinel sites were established in central and southern Malawi (Fig. 1). In 2008 four of these sites (Kamtekete, Kalungama, Makoka, and Mazandua) were in the IRS area. In 2009 a fifth site, Ambali, became an IRS site.

Blood-fed and gravid indoor resting An. gambiae and An. funestus adult female mosquitoes were routinely collected between 0600–1000 h using an aspirator. Mosquitoes were kept in individual oviposition tubes and induced to lay eggs. Egg batches from females collected at each sentinel site were pooled and reared together to avoid bias from isofemale lines.

Insecticide Bioassays.

Insecticide susceptibility assays were carried out using 1- to 3-d-old F1 adults according to the WHO protocol at 25 ± 2 °C and 70–80% relative humidity (28). Between 5 and 25 adult mosquitoes were exposed to insecticide-treated or control papers (impregnated with insecticide carrier oil) for 1 h and then held with access to 10% sugar solution for 24 h before the percentage mortality was determined. The insecticides and diagnostic dosages tested were bendiocarb (0.1%), deltamethrin (0.05%), lambda cyhalothrin (0.05%), permethrin (0.75%), pirimiphos methyl (0.9%), malathion (5%), and DDT (4%). All papers, with the exception of the pirimiphos methyl papers, which were made immediately before use without carrier oil (27), where purchased from WHO.

Species Identification.

All mosquitoes were morphologically identified as belonging to the An. gambiae complex or An. funestus group (28, 29). Identification to species level was carried out by PCR (30, 31).

Biochemical Assays.

Standard biochemical assays for GST, altered AChE, esterase (using both pNPA rate reactions and α- and β-naphthyl acetate end point assays), and monooxygenase (P450) quantification were carried out according to the methods described previously (32) using 30 1- to 3-d-old female An. funestus adults from the Chikwawa mixed F1 mosquito pool. The An. gambiae Kisumu strain (33) was used as the susceptible control sample, because susceptible An. funestus were not available. A two-sample t test was used to compare results between strains after adjustments for total protein content. The adjusted mean enzyme level/activity of Chikwawa were compared with the corresponding Kisumu means.

Sodium Channel Gene Sequencing for Detection of kdr Mutations.

The target site-based pyrethroidDDT resistance known as kdr was assessed by sequencing a fragment of the sodium channel gene in An. funestus. This spanned the 1014 codon in exon 20 (domain II, segment 6) associated with kdr resistance in An. gambiae (7, 8). It was assessed in pyrethroid resistant and susceptible mosquitoes from Chikwawa to correlate the presence of any mutation with pyrethroid resistance. DNA was extracted using the LIVAK method (36) and amplified using primers Kdrfun-F GTT CAA TGA AGC CCC TCA AA and Kdrfun-R CCG AAA TTT GAC AAA AGC AAA. The PCR was carried out using 10 pmol of each primer and 30 ng of genomic DNA as template in 25-μL reactions containing 1× Kapa Taq buffer, 0.2 mM dNTPs, 1.5 mM MgCl2, and 1 U Kapa Taq (Kapa Biosystems). The cycle parameters were 1 cycle at 95 °C for 5 min; 35 cycles of 94 °C for 30 s, 57 °C for 30s, and elongation at 72 °C for 1 min; followed by 1 cycle at 72 °C for 10 min. Sequences were aligned using ClustalW (37), whereas haplotype reconstruction and polymorphism analysis was done using DnaSP v5.0 (36). The phylogenetic neighbor-joining trees were constructed using MEGA 4.0 (37).

AChE Sequencing.

Target site-based organophosphate andor carbamate resistance was assessed by sequencing a fragment of the AChE gene (accession no. DQ534435). This spanned the G119S and F455W mutations previously associated with carbamate resistance (19, 38). The region was amplified and sequenced in individual carbamate resistant and susceptible mosquitoes from Chikwawa. The following primers were used for the PCR amplification: AChE forward CCA CTG TCG GAG GAC TGT CT and AChE reverse CGT TAA CGT ACG GGT CGA GT. The PCR was carried out using 10 pmol of each primer and 30 ng of genomic DNA (gDNA) as template in 25-μL reactions containing 1× Kapa Taq buffer, 0.2 mM dNTPs, 1.5 mM MgCl2, and 1 U Kapa Taq. The cycle parameters were as follows: 1 cycle at 95 °C for 5 min; 35 cycles of 94 °C for 30 s, 57 °C for 30 s, and elongation at 72 °C for 1 min; followed by 1 cycle at 72 °C for 10 min.

Genotyping An. funestus Samples for Detection of 1014 kdr and 119 Ace-1 Mutations Using Pyrosequencing.

Pyrosequencing was used to genotype the positions of the known 1014 kdr and 119 Ace-1 mutations as described for kdr genotyping in Culex quinquefasciatus (39). The pyrosequencing AB software was used to design three sequence-specific primers for Ace-1 and kdr mutations (the L1014F and L1014S kdr-variants are detected in the same assay). The sequences for genotyping analysis and the dispensation order for both reactions are the same as previously described (40). Target DNA fragments for kdr and Ace-1 were first amplified by PCR using the forward and biotinylated reverse primers. The PCR contained forward and biotinylated reverse primers (10 pmol), 1× HotStarTaq buffer, 0.2 mM dNTPs, 1.5 mM MgCl2, 1 U HotStarTaq (Qiagen), and 10 ng gDNA. The parameters for amplification were as follows: 1 cycle at 95 °C for 5 min; 50 cycles of 94 °C for 20 s, 57 °C for 30 s, and elongation at 72 °C for 20 s; followed by 1 cycle at 72 °C for 5 min.

Pyrosequencing reactions were performed as previously described (40) according to the manufacturers instructions using the PSQ 96 SNP Reagent Kit (Biotage) and the sequencing primer. The genotype was automatically determined by the pyrosequencer.

Transcription Profiling of Relevant P450 Genes.

Quantitative PCR analysis of mosquitoes for two duplicated P450 genes (CYP6P9a and CYP6P9b) previously found to be associated with pyrethroid resistance in the FUMOZ-R strain of An. funestus (17) and in field samples of An. funestus from Mozambique (21) were carried out to assess whether they were also over expressed in the Malawian An. funestus field samples. The GeXP genetic analysis system from Beckman Coulter was used according to the protocol in ref. 17. RNA was extracted using the Picopure RNA isolation kit (Arkturis) from three batches of 10 females from Chikwawa, respectively, for resistant to permethrin, bendiocarb resistant, and for females not exposed to insecticides (as control for the population). The same was done for the laboratory susceptible FANG strain of An. funestus (originally from Angola) (41). The FANG mRNA was stored in RNA later, hence whole insect samples were not available for the biochemical assays. RNA quality was assessed using the Agilent 2100 Bioanalyzer. The following primers were used: CYP6P9a forward AGG TGA CAC TAT AGA ATA CAA TGT GAT AAA CGA AAC ACT TCG CAA (common to both CYP6p9 copies and spanning the intron); CYP6P9a reverse GTA CGA CTC ACT ATA GGG ACT TTA TTA TAG ATT GGA AGT ATC TCA (expected product of 490 bp); CYP6P9b reverse GTA CGA CTC ACT ATA GGG ACT ACA AAA ACC CCT TCC GCT GCA CC (expected product of 504 bp). The expression level of the RSP7 ribosomal gene, shown to be consistent and with no differential expression between susceptible and resistant (17, 18), was used to normalize for variation in total cDNA concentration between samples. A two-sample t test was used to compare the results between samples.

Household Surveys.

Cross-sectional household surveys were carried out at each sentinel site on a random sample of 140 1- to 4-y-old children. Households were selected from strata formed by dividing sentinel sites into quadrants from which participants were selected, to ensure the greatest geographical spread within the site. Diagnostic tests with ICT malaria rapid tests (ICT, Global Diagnostics) were used to assess the P. falciparum infection status of each of the sampled children. Participants who tested positive were offered treatment with Coartem (Novartis) (artemether and lumefantrine) according to Malawis national malaria treatment guidelines.

Household surveys were carried out in April at the end of the 2009 and 2010 malaria transmission seasons. The sentinel site-specific sample size was calculated to provide evidence at the 5% significance level of an absolute reduction in P. falciparum prevalence of 20% following the intervention. Prevalence and 95% CIs for each sentinel site were estimated, taking account of clustering by sentinel site using the statistical software package STATA, release 10 (StataCorp).

Sentinel sites were considered the primary sampling unit. Logistic regression, allowing for complex survey designs, was performed to estimate the mean effect of the intervention on prevalence compared with baseline prevalence of infection in different years.

Ethics.

Ethics approval for this work was obtained from the ethics committees of the College of Medicine (COMREC) in Malawi and Liverpool School of Tropical Medicine in the United Kingdom.

Previous SectionNext Section

Acknowledgments

This study was partly funded by Wellcome Trust Grant 083515/Z/07/Z, as part of a Research Career Development Fellowship for C.S.W.

Previous SectionNext Section

Footnotes

1C.S.W. and M.C. contributed equally to this work.

2To whom correspondence should be addressed. E-mail: hemingway@liverpool.ac.uk.

This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2010.

Author contributions: C.S.W., M.C., I.K., and J.H. designed research; C.S.W., M.C., T.M., H.I., M.N., A.R., J.M., K.G.B., and J.H. performed research; C.S.W., M.C., I.K., T.M., H.I., M.N., A.R., J.M., K.G.B., and J.H. contributed new reagents/analytic tools; C.S.W., M.C., I.K., and J.H. analyzed data; and C.S.W., M.C., and J.H. wrote the paper.

The authors declare no conflict of interest.

Data deposition: The sequences reported in this paper has been deposited in the GenBank database (accession nos. JN815112, JN815113, JN815114, JN815115, and JN815116).

Freely available online through the PNAS open access option.

 

References

Campbell CC, Steketee RW

(2011) Malaria in Africa can be eliminated. Am J Trop Med Hyg 85(4):584–585.

Abstract/FREE Full Text

Eisele TP, et al.

(2012) Estimates of child deaths prevented from malaria prevention scale-up in Africa 2001-2010. Malar J 11(1):93.

CrossRefMedline

Ranson H, et al.

(2011) Pyrethroid resistance in African anopheline mosquitoes: What are the implications for malaria control? Trends Parasitol 27(2):91–98.

CrossRefMedlineWeb of Science

Coleman M, Sharp B, Seocharan I, Hemingway J

(2006) Developing an evidence-based decision support system for rational insecticide choice in the control of African malaria vectors. J Med Entomol 43(4):663–668.

CrossRefMedlineWeb of Science

World Health Organization

(1980) Resistance of Vectors of Disease to Pesticides. Technical Report Series 655 (WHO, Geneva).

Hemingway J, Ranson H

(2000) Insecticide resistance in insect vectors of human disease. Annu Rev Entomol 45:371–391.

CrossRefMedlineWeb of Science

Martinez-Torres D, et al.

(1998) Molecular characterization of pyrethroid knockdown resistance (kdr) in the major malaria vector Anopheles gambiae s.s. Insect Mol Biol 7(2):179–184.

CrossRefMedlineWeb of Science

Ranson H, et al.

(2000) Identification of a point mutation in the voltage-gated sodium channel gene of Kenyan Anopheles gambiae associated with resistance to DDT and pyrethroids. Insect Mol Biol 9(5):491–497.

Brooke BD, et al.

(2001) Bioassay and biochemical analyses of insecticide resistance in southern African Anopheles funestus (Diptera: Culicidae) Bull Entomol Res 91(4):265–272.

MedlineWeb of Science

National Malaria Control Programme

(2011) National Malaria Control Programme Annual Report (National Malaria Control Programme, Lilongwe, Malawi).

Casimiro SL, Coleman M, Mohloai P, Hemingway J, Sharp B

(2006) Insecticide resistance in Anopheles funestus (Diptera: Culicidae) from Mozambique. J Med Entomol 43(2):267–275.

CrossRefMedlineWeb of Science

Casimiro SL, Hemingway J, Sharp BL, Coleman M

(2007) Monitoring the operational impact of insecticide usage for malaria control on Anopheles funestus from Mozambique. Malar J 6:142.

Corbel V, et al.

(2003) Evidence for selection of insecticide resistance due to insensitive acetylcholinesterase by carbamate-treated nets in Anopheles gambiae s.s. (Diptera: Culicidae) from Cote dIvoire. J Med Ent 40(6):985–988.

Mosha FW, et al.

(2008) Comparative efficacies of permethrin-, deltamethrin- and alpha-cypermethrin-treated nets, against Anopheles arabiensis and Culex quinquefasciatus in northern Tanzania. Ann Trop Med Parasitol 102(4):367–376.

NGuessan R, Corbel V, Akogbéto M, Rowland M

(2007) Reduced efficacy of insecticide-treated nets and indoor residual spraying for malaria control in pyrethroid resistance area, Benin. Emerg Infect Dis 13(2):199–206.

CrossRefMedlineWeb of Science

Hargreaves K, et al.

(2000) Anopheles funestus resistant to pyrethroid insecticides in South Africa. Med Vet Entomol 14(2):181–189.

CrossRefMedlineWeb of Science

Wondji CS, et al.

(2009) Two duplicated P450 genes are associated with pyrethroid resistance in Anopheles funestus, a major malaria vector. Genome Res 19(3):452–459.

Abstract/FREE Full Text

Morgan JC, Irving H, Okedi LM, Steven A, Wondji CS

(2010) Pyrethroid resistance in an Anopheles funestus population from Uganda. PLoS ONE 5(7):e11872.

CrossRefMedline

Djogbénou L, et al.

(2008) Identification and geographic distribution of the ACE-1R mutation in the malaria vector Anopheles gambiae in south-western Burkina Faso, West Africa. Am J Trop Med Hyg 78(2):298–302.

Abstract/FREE Full Text

Nabeshima T, et al.

(2004) An amino acid substitution attributable to insecticide-insensitivity of acetylcholinesterase in a Japanese encephalitis vector mosquito, Culex tritaeniorhynchus. Biochem Biophys Res Commun 313(3):794–801.

CrossRefMedline

Cuamba N, Morgan JC, Irving H, Steven A, Wondji CS

(2010) High level of pyrethroid resistance in an Anopheles funestus population of the Chokwe District in Mozambique. PLoS ONE 5(6):e11010.

CrossRefMedline

Müller P, et al.

(2008) Field-caught permethrin-resistant Anopheles gambiae overexpress CYP6P3, a P450 that metabolises pyrethroids. PLoS Genet 4(11):e1000286.

CrossRefMedline

Kleinschmidt I, et al.

(2009) Combining indoor residual spraying and insecticide-treated net interventions. Am J Trop Med Hyg 81(3):519–524.

Abstract/FREE Full Text

García GP, et al.

(2009) Recent rapid rise of a permethrin knock down resistance allele in Aedes aegypti in México. PLoS Negl Trop Dis 3(10):e531.

CrossRefMedline

García C, García L, Espinosa-Carreón L, Ley C

(2011) [Abundance and distribution of Aedes aegypti (Diptera: Culicidae), and dengue dispersion in Guasave Sinaloa, Mexico] Rev Biol Trop 59(4):1609–1619.

 

World Health Organisation

(1981) Instructions for Determining the Susceptibility or Resistance of Adult Mosquitoes to Organochorine, Organophosphorus and Carbamate Insecticides. WHO VBC 81.805 (WHO, Geneva).

Hemingway J, Rowland M, Kissoon KE

(1984) Efficacy of pirimiphos methyl as a larvicide or adulticide against insecticide resistant and susceptible mosquitos (Diptera, Culicidae) J. Econ Ent 77(4):868–871.

Medline

Gillies MT, DeMeillon B

(1968) The Anophelinae of Africa South of the Sahara (The South African Institute for Medical Research).

 

Gillies MT, Coetzee M

(1987) A Supplement to: The Anophelinae of Africa South of the Sahara (The South African Institute for Medical Research).

 

Scott JA, Brogdon WG, Collins FH

(1993) Identification of single specimens of the Anopheles gambiae complex by the polymerase chain reaction. Am J Trop Med Hyg 49(4):520–529.

Abstract/FREE Full Text

Koekemoer LL, Kamau L, Hunt RH, Coetzee M

(2002) A cocktail polymerase chain reaction assay to identify members of the Anopheles funestus (Diptera: Culicidae) group. Am J Trop Med Hyg 66(6):804–811.

Abstract

Penilla RP, et al.

(1998) Resistance management strategies in malaria vector mosquito control. Baseline data for a large-scale field trial against Anopheles albimanus in Mexico. Med Vet Entomol 12(3):217–233.

CrossRefMedlineWeb of Science

Vulule JM, et al.

(1994) Reduced susceptibility of Anopheles gambiae to permethrin associated with the use of permethrin-impregnated bednets and curtains in Kenya. Med Vet Entomol 8(1):71–75.

MedlineWeb of Science

 

Collins FH, et al.

(1987) A ribosomal RNA gene probe differentiates member species of the Anopheles gambiae complex. Am J Trop Med Hyg 37(1):37–41.

Abstract/FREE Full Text

 

Thompson JD, Higgins DG, Gibson TJ

(1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22(22):4673–4680.

Abstract/FREE Full Text

Librado P, Rozas J

(2009) DnaSP v5: A software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25(11):1451–1452.

Abstract/FREE Full Text

Tamura K, Dudley J, Nei M, Kumar S

(2007) MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24(8):1596–1599.

Abstract/FREE Full Text

Weill M, et al.

(2003) Comparative genomics: Insecticide resistance in mosquito vectors. Nature 423(6936):136–137.

Medline

Wondji CS, Priyanka De Silva WA, Hemingway J, Ranson H, Parakrama Karunaratne SH

(2008) Characterization of knockdown resistance in DDT- and pyrethroid-resistant Culex quinquefasciatus populations from Sri Lanka. Trop Med Int Health 13(4):548–555.

CrossRefMedline

Djouaka R, Irving H, Tukur Z, Wondji CS

(2011) Exploring mechanisms of multiple insecticide resistance in a population of the malaria vector Anopheles funestus in Benin. PLoS ONE 6(11):e27760.

CrossRefMedline

Hunt RH, Brooke BD, Pillay C, Koekemoer LL, Coetzee M

(2005) Laboratory selection for and characteristics of pyrethroid resistance in the malaria vector Anopheles funestus. Med Vet Entomol 19(3):271–275.

ect�Knp�ox� estus. Med Vet Entomol 19(3):271–275.

41197599